Is Retatrutide (GLP-3) Safe During Pregnancy or Breastfeeding?

Direct Answer

No, retatrutide is contraindicated during both pregnancy and breastfeeding. Clinical trials specifically excluded pregnant and breastfeeding women, meaning there is zero controlled safety data on how the medication affects a developing fetus or a nursing infant. This isn't a cautious guess, it's a direct, stated exclusion built into the trial design itself.

Why This Exclusion Matters

Infants and developing fetuses have immature metabolic, digestive, and endocrine systems, genuinely different from an adult's, meaning safety data in adults doesn't reliably predict safety in these populations. Without dedicated studies, there's no real, evidence-based way to assess risk one way or the other, which is exactly why regulatory and clinical guidance defaults to contraindication rather than assumption.

If You're Currently Breastfeeding and Considering Stopping

Retatrutide's roughly 6-day half-life means it would take meaningful time to fully clear your system, making a short "pause and resume" approach an ineffective, unreliable safety strategy given the complete absence of underlying data either way. If you're breastfeeding, the current guidance is to wait until you've fully weaned before starting, not to attempt a temporary interruption.

A Related Consideration

This same reasoning applies to compounded or grey-market retatrutide, since no legitimate version of this medication currently has pregnancy or lactation safety data, that's true regardless of how or where it's obtained, not something a compounding pharmacy or online seller can responsibly claim to have resolved.

Bottom Line

If you are pregnant, trying to become pregnant, or currently breastfeeding, retatrutide is not an appropriate option right now, given the complete absence of safety data in these specific populations. This is a genuine, real exclusion, not a general precaution applied loosely.

References

• RetatrutidePen.co.uk: Retatrutide and Breastfeeding, Safety Risks & Guidelines (2026)
• Trimi Health: Retatrutide Cost Tracker, Contraindications Summary (May 2026)

Related Resources

• Is It Safe to Take a GLP-1 Medication While Breastfeeding?

Explore More

Explore the full GLP-1 Tracker knowledge base on DietApp.com

Get Started

Track retatrutide alongside every other GLP-1 medication on DietApp.com.

About DietApp.com

DietApp.com combines evidence-based GLP-1 medication education with practical treatment tracking tools. Retatrutide is investigational and not FDA-approved. This article is for general informational purposes and is not medical advice.